Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate
Abstract Diarrhea caused by Shigella has been associated with high morbidity and mortality in young children worldwide. There are no licensed vaccines, and those clinically advanced have restricted coverage as they elicit serotype-specific immunity while disease is caused by multiple circulating ser...
Main Authors: | Girmay Desalegn, Chitradevi S. Tamilselvi, Jose M. Lemme-Dumit, Shannon J. Heine, Dylan Dunn, Esther Ndungo, Neeraj Kapoor, Edwin V. Oaks, Jeff Fairman, Marcela F. Pasetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-023-00797-6 |
Similar Items
-
A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes
by: Girmay Desalegn, et al.
Published: (2023-06-01) -
Engineered and construction of pDS132::∆virG as suicide vector for targeted gene deletion of virG from Shigella flexneri 2a in order to generation a live attenuated Shigella vaccine
by: Mojtaba Saadati, et al.
Published: (2011-12-01) -
Analysis on the Interaction Domain of VirG and Apyrase by Pull-Down Assay
by: Yu Wang, et al.
Published: (2014-11-01) -
Functional antibodies as immunological endpoints to evaluate protective immunity against Shigella
by: Esther Ndungo, et al.
Published: (2020-01-01) -
Epithelial and Neutrophil Interactions and Coordinated Response to Shigella in a Human Intestinal Enteroid-Neutrophil Coculture Model
by: Jose M. Lemme-Dumit, et al.
Published: (2022-06-01)